Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
dermal absorption in vitro / ex vivo
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Study cited by: CIR, 2011. Decyl Glucoside and Other Alkyl Glucosides as Used in Cosmetics. Final Safety Assessment.

Data source

Reference
Reference Type:
secondary source
Title:
Unnamed
Year:
2009

Materials and methods

GLP compliance:
yes

Test material

Constituent 1
Reference substance name:
Caprylyl/Capryl Glucoside
IUPAC Name:
Caprylyl/Capryl Glucoside
Test material form:
not specified
Radiolabelling:
no

Administration / exposure

Vehicle:
other: 10% in Hanks’ buffered salt solution
Details on in vitro test system (if applicable):
Two human skin samples from each of three donors were used in the study (n=6). The receptor fluid was Krebs ringer’s bicarbonate buffer without HEPES and glucose.

Results and discussion

Total recovery:
After 24 h, the mean recovery was 0.52% of caprylyl/capryl glucoside from two tape strips and 0.30% of caprylyl/capryl glucoside in the further 18 tape strips. The mean amount of caprylyl/capryl glucoside removed from the skin (by washing) ranged from 109-145% of the dose applied. The mean absorbed dose of caprylyl/capryl glucoside, as the sum of the amounts found in the viable epidermis, dermis, and receptor medium, was 0.01%.

Applicant's summary and conclusion

Conclusions:
The mean absorbed dose of caprylyl/capryl glucoside, as the sum of the amounts found in the viable epidermis, dermis, and receptor medium, was 0.01%.
Executive summary:

The dermal penetration of caprylyl/capryl glucoside was evaluated in vitro using human skin. The mean absorbed dose, as the sum of the amounts found in the viable epidermis, dermis, and receptor medium, was 0.01%.